Sipuleucel-T and Ipilimumab for Advanced Prostate Cancer

Completed · Phase 1

Conditions studied: Prostate Cancer, Castrate Resistant Prostate Cancer

In brief

This is a clinical trial designed to quantify the immune response and determine the tolerability and side effects of sipuleucel-T when given in combination with ipilimumab for patients with advanced prostate cancer.

Key facts

Study ID

NCT01832870

Run by

Prostate Oncology Specialists, Inc.

People needed

9

Starts

2013-04-01

Expected to finish

2016-02-01

Last updated by the study team

2017-08-24

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Subjects with advanced prostate cancer who are eligible to receive sipuleucel-T in accordance with FDA approved labeling of sipuleucel-T
• Subjects must understand and sign an informed consent form

You may not qualify if…

• Subjects who are not eligible to receive sipuleucel-T

Where it is running

• Prostate Oncology Specialists, Inc. — Marina del Rey, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.